RNU6-909P

Across TCGA pan-cancer cohorts, RNU6-909P RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated RNU6-909P data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RNU6-909P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-909P expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

UCEC, CHOL, and THCA are the cancer types where RNU6-909P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	All	0.676	0.901	<.001	102	view →
CHOL	OS	Tertile	All	0.024	0.675	<.001	99	view →
THCA	OS	Tertile	All	0.827	0.978	<.001	99	view →
UCS	DFS	Tertile	IV	0.132	0.718	.002	54	view →
LUSC	DFS	Tertile	All	0.215	0.526	.003	42	view →
PCPG	OS	Tertile	All	0.595	0.981	<.001	42	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
SARC	OS	Tertile	All	0.134	0.524	<.001	36	view →
LGG	DFS	Tertile	All	0.442	0.741	.008	18	view →
SKCM	DFS	Tertile	All	0.344	0.181	.013	15	view →
PRAD	OS	Tertile	All	0.966	0.995	.026	12	view →
KICH	OS	Tertile	All	0.648	0.972	.012	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

RNU6-909P–UCEC (DFS)

Open the UCEC breakdown →